Home
Resources
Publications
In Vitro and in Vivo Reversal of MDR1-mediated Multidrug Resistance by KT-5720: Implications on Hematological Malignancies

In Vitro and in Vivo Reversal of MDR1-mediated Multidrug Resistance by KT-5720: Implications on Hematological Malignancies

Hanan Galski, Hamutal Sivan, Philip Lazarovici, Arnon Nagler

Leuk Res. 2006 Sep;30(9):1151-8.

PMID: 16542724

Abstract:

Multidrug resistance (MDR) due to over-expression of the MDR1 (ABCB1) gene and its P-glycoprotein (Pgp) product is an obstacle in the treatment of hematological malignancies. In this study, we have evaluated the potency of KT-5720 to reverse Pgp-dependent MDR in vitro and in vivo. KT-5720 (but not its close derivatives, K252a and K252b) reversed multidrug resistance of LM1/MDR cell line at non-toxic concentrations and increased accumulation of rhodamine 123 (Rh123). KT-5720 significantly reversed MDR1-dependent resistance of primary malignant cells from patients with chronic myelogenous leukemia in blast crisis (CML-BC) and advanced multiple myeloma (MM). Moreover, KT-5720 (at 5 mg/kg) sensitized the bone marrow of MDR1 transgenic mice model towards daunorubicin (at 8 mg/kg) without general toxic effects. Therefore, KT-5720 can be considered as candidate for combination therapy in various hematological malignancies where Pgp activity is a major impediment for cure.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP108068980-B	KT 5720		108068-98-0	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: